ScienceDex / Researcher record
Olivier, Kenneth
- Boston Immune Technologies and Therapeutics, Inc. (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Sustained Excellence
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2015 | $3,497,593 | 3 | #1,154 |
| 2016 | $1,750,913 | 3 | #3,258 |
| 2017 | $1,577,493 | 3 | #3,762 |
| 2018 | $2,420,816 | 3 | #2,077 |
| 2019 | $3,568,490 | 3 | #1,169 |
| 2021 | $4,884,525 | 4 | #734 |
| 2022 | $4,547,328 | 3 | #855 |
| 2023 | $1,519,733 | 2 | #5,688 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20153 records
- FY20163 records
- FY20173 records
- FY20183 records
- FY20193 records
- FY20214 records
- FY20223 records
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2015 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Olivier, Kenneth as a PI. Multi-PI records show the full award amount for context.
- 4R44CA265510-02R44Contact PIPreclinical toxicology and pharmacology evaluation of a newTNFR2 antagonistic monoclonal antibody for CTCL therapy$1.2Maward amount
- 1R44AI179385-01R44Contact PIAdvancing BITT-101 a novel dominant CD40 antagonist for use in treatment of Sjogren Syndrome.$298Kaward amount
Award organization
Organizations that administered FY2023 awards listing Olivier, Kenneth as a PI.
FY2023 award administered by Boston Immune Technologies and Therapeutics, Inc. (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2015First NIH AwardBoston Immune Technologies and Therapeutics, Inc.
- 2015$500K Cumulative Funding
- 2015$1M Cumulative Funding
- 2015$2M Cumulative Funding
- 2015Entered Top 50% NationallyRanked #1154
- 2015Entered Top 25% NationallyRanked #1154
- 2015Entered Top 10% NationallyRanked #1154
- 2016$5M Cumulative Funding
- 2019$10M Cumulative Funding
- 2021Entered Top 5% NationallyRanked #734